1-1 of 1
John Silowsky, RN BSN
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Cael-101 Is Well-Tolerated in AL Amyloidosis Patients Receiving Concomitant Cyclophosphamide-Bortezomib-Dexamethasone (CyborD): A Phase 2 Dose-Finding Study (NCT04304144)

Jason Valent, MD, John Silowsky, RN BSN, Michael R. Kurman, MD, Eileen Daniel, Janet Jobes, Mark Harnett, MS, Margaret Ziola, MD, Jessica Roviwong, Sherry Fada, Michael Spector, BS, Susan B. Sobolov, PhD
Journal: Blood
Blood (2020) 136 (Supplement 1): 26–27.
https://doi.org/10.1182/blood-2020-139323
Published: 2020